BIOMAT Database Logo BIOMAT Database Logo

The prevalence of tardive dyskinesia. 1985

J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
Prevalence of tardive dyskinesia.
December 1979, The Journal of clinical psychiatry,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
Characterization and prevalence of tardive dyskinesia.
July 1978, The Journal of clinical psychiatry,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
The prevalence of tardive dyskinesia in geropsychiatric outpatients.
February 1985, The Journal of clinical psychiatry,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
Tardive dyskinesia in India: a prevalence study.
October 1982, Journal of clinical psychopharmacology,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
[Tardive dyskinesia: clinical picture, prevalence, and pathophysiology].
April 1983, Fortschritte der Neurologie-Psychiatrie,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong.
August 1992, The American journal of psychiatry,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
Factors influencing the prevalence and severity of tardive dyskinesia.
January 1984, Psychopharmacology bulletin,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
The prevalence of tardive dyskinesia in fluphenazine-treated patients.
August 1988, Journal of clinical psychopharmacology,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
Sex differences in the prevalence of severe tardive dyskinesia.
August 1979, The American journal of psychiatry,
J M Kane, and M Woerner, and J A Lieberman, and P Weinhold, and W Florio, and M Rubinstein, and J Rotrosen, and J Kurucz, and S Mukherjee, and K Bergmann
Relation of age to prevalence of tardive dyskinesia.
January 1992, The American journal of psychiatry,
Copied contents to your clipboard!